QSI

0.909015.05%
JA

Jeffrey Alan Hawkins

President, CEO & Director

Mr. Jeffrey Alan Hawkins, also known as Jeff, serves as Chief Executive Officer at Quantum-Si incorporated since joining from October 10, 2022 and serves as its Director since October 2022 also serves as it's President Since August 28, 2023. He serves as Technology Advisor of Truvian Sciences, Inc. since July 2022. Mr. Hawkins served as President, Chief Executive Officer and Director of Truvian Sciences from January 2018 to July 2022, where he led the evolution of the companys benchtop blood testing system from a product concept through technology feasibility and into late-stage development. Prior to Truvian, Mr. Hawkins led the Reproductive and Genetic Health Business Unit at Illumina Inc., where he oversaw the rapid global growth of next-generation sequencing into new and emerging markets. Mr. Hawkins served as Senior Vice President of Global Marketing and Program Management at GenMark Diagnostics, Inc. from March 2014 to October 23, 2015. Mr. Hawkins served as Senior Vice President of Marketing and Business Development at GenMark Diagnostics, Inc., from November 2010 to March 2014. He served as Senior Vice President of Business Development at GenMark Diagnostics, Inc. since October 2011. He served in senior marketing, product development and operations roles with Hologic Inc., Third Wave Technologies Inc., Sysmex America and Abbott Laboratories. He serves as a Director of Ohmx Corporation. He has experience at the worlds leading life science and diagnostics companies as an accomplished business leader and inventor. He is co-inventor on few issued or pending patents spanning consumables, instrumentation, optics, manufacturing methods and designs. Mr. Hawkins received a B.A. in Chemistry with honors from Concordia University and an MBA from Keller Graduate School of Management.

Positions